A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?

Abstract Background The 2016 American Thyroid Association guidelines indicate that patients with Graves’ disease who undergo a thyroidectomy should be rendered euthyroid through the use of antithyroid drugs (ATD) prior to surgery to avoid complications such as a thyroid storm. At times, the use of A...

Full description

Saved in:
Bibliographic Details
Main Authors: Abrar Al Jassim, Tim Wallace, Sarah Bouhabel, Agnieszka Majdan, Michael Hier, Veronique-Isabelle Forest, Richard Payne
Format: Article
Language:English
Published: SAGE Publishing 2018-05-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-018-0281-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832569099875516416
author Abrar Al Jassim
Tim Wallace
Sarah Bouhabel
Agnieszka Majdan
Michael Hier
Veronique-Isabelle Forest
Richard Payne
author_facet Abrar Al Jassim
Tim Wallace
Sarah Bouhabel
Agnieszka Majdan
Michael Hier
Veronique-Isabelle Forest
Richard Payne
author_sort Abrar Al Jassim
collection DOAJ
description Abstract Background The 2016 American Thyroid Association guidelines indicate that patients with Graves’ disease who undergo a thyroidectomy should be rendered euthyroid through the use of antithyroid drugs (ATD) prior to surgery to avoid complications such as a thyroid storm. At times, the use of ATDs can have limited efficacy and therefore some patients will inevitably remain biochemically hyperthyroid at the time of surgery. The aim of this study is to assess if hyperthyroid patients undergoing a thyroidectomy are at an increased risk of developing a thyroid storm in comparison to euthyroid patients. Furthermore, this study seeks to establish a correlation between thyroid storm identified by the levels of thyroid hormones (T3 and T4) and the level of thyroid stimulating hormone (TSH). Methods A retrospective cohort study was conducted at two Canadian centers, one in Montreal and the other in Nova Scotia. Sixty-seven patients undergoing thyroidectomy for Graves’ disease from January 2006 to December 2016 were evaluated. Results The study comprised 67 participants with a mean age of 46 years (range16–78 years). A total of 78% of patients were on methimazole, 34% on beta-blockers, 27% on potassium iodine solution, 10% on propylthiouracil and 7% on steroids. At the time of surgery 21% were in an overt hyperthyroid state and 33% were in a subclinical hyperthyroid state. The average TSH level of 0.03 mIUL/L (range 0.01–0.23 mIUL/L). Sixteen percent of patients had a TSH level less than 0.01 mIUL/L. The average free T4 level was 29.58 pmol/L (range 11.5–95.2 pmol/L). The average total T3 level was 11.52 nmol/L (range 4.5–29.1 nmol/L) and free T3 level was 6.35 pmol/L (range 6.1–6.6 pmol/L). No patient developed thyroid storm. Conclusions In our study, biochemically hyperthyroid patients undergoing thyroidectomy did not develop thyroid storm. Additional studies with larger sample sizes are needed to better understand the risk of thyroid storm in hyperthyroid patients.
format Article
id doaj-art-1e730abc93bb425bba60be55833823f5
institution Kabale University
issn 1916-0216
language English
publishDate 2018-05-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-1e730abc93bb425bba60be55833823f52025-02-02T23:08:46ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162018-05-014711510.1186/s40463-018-0281-zA retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?Abrar Al Jassim0Tim Wallace1Sarah Bouhabel2Agnieszka Majdan3Michael Hier4Veronique-Isabelle Forest5Richard Payne6Department of Otolaryngology – Head and Neck surgery, Jewish General Hospital, McGill UniversityDepartment of Otolaryngology – Head and Neck surgery, Cumberland Regional Health Care Center, Dalhousie UniversityDepartment of Otolaryngology – Head and Neck surgery, Jewish General Hospital, McGill UniversityDivision of Endocrinology, Jewish General Hospital, McGill UniversityDepartment of Otolaryngology – Head and Neck surgery, Jewish General Hospital, McGill UniversityDepartment of Otolaryngology – Head and Neck surgery, Jewish General Hospital, McGill UniversityDepartment of Otolaryngology – Head and Neck surgery, Jewish General Hospital, McGill UniversityAbstract Background The 2016 American Thyroid Association guidelines indicate that patients with Graves’ disease who undergo a thyroidectomy should be rendered euthyroid through the use of antithyroid drugs (ATD) prior to surgery to avoid complications such as a thyroid storm. At times, the use of ATDs can have limited efficacy and therefore some patients will inevitably remain biochemically hyperthyroid at the time of surgery. The aim of this study is to assess if hyperthyroid patients undergoing a thyroidectomy are at an increased risk of developing a thyroid storm in comparison to euthyroid patients. Furthermore, this study seeks to establish a correlation between thyroid storm identified by the levels of thyroid hormones (T3 and T4) and the level of thyroid stimulating hormone (TSH). Methods A retrospective cohort study was conducted at two Canadian centers, one in Montreal and the other in Nova Scotia. Sixty-seven patients undergoing thyroidectomy for Graves’ disease from January 2006 to December 2016 were evaluated. Results The study comprised 67 participants with a mean age of 46 years (range16–78 years). A total of 78% of patients were on methimazole, 34% on beta-blockers, 27% on potassium iodine solution, 10% on propylthiouracil and 7% on steroids. At the time of surgery 21% were in an overt hyperthyroid state and 33% were in a subclinical hyperthyroid state. The average TSH level of 0.03 mIUL/L (range 0.01–0.23 mIUL/L). Sixteen percent of patients had a TSH level less than 0.01 mIUL/L. The average free T4 level was 29.58 pmol/L (range 11.5–95.2 pmol/L). The average total T3 level was 11.52 nmol/L (range 4.5–29.1 nmol/L) and free T3 level was 6.35 pmol/L (range 6.1–6.6 pmol/L). No patient developed thyroid storm. Conclusions In our study, biochemically hyperthyroid patients undergoing thyroidectomy did not develop thyroid storm. Additional studies with larger sample sizes are needed to better understand the risk of thyroid storm in hyperthyroid patients.http://link.springer.com/article/10.1186/s40463-018-0281-zGraves’ diseaseThyroid stormThyroidectomyHyperthyroidThyroid hormonesAmerican Thyroid Association guidelines
spellingShingle Abrar Al Jassim
Tim Wallace
Sarah Bouhabel
Agnieszka Majdan
Michael Hier
Veronique-Isabelle Forest
Richard Payne
A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
Journal of Otolaryngology - Head and Neck Surgery
Graves’ disease
Thyroid storm
Thyroidectomy
Hyperthyroid
Thyroid hormones
American Thyroid Association guidelines
title A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
title_full A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
title_fullStr A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
title_full_unstemmed A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
title_short A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
title_sort retrospective cohort study do patients with graves disease need to be euthyroid prior to surgery
topic Graves’ disease
Thyroid storm
Thyroidectomy
Hyperthyroid
Thyroid hormones
American Thyroid Association guidelines
url http://link.springer.com/article/10.1186/s40463-018-0281-z
work_keys_str_mv AT abraraljassim aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT timwallace aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT sarahbouhabel aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT agnieszkamajdan aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT michaelhier aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT veroniqueisabelleforest aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT richardpayne aretrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT abraraljassim retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT timwallace retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT sarahbouhabel retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT agnieszkamajdan retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT michaelhier retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT veroniqueisabelleforest retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery
AT richardpayne retrospectivecohortstudydopatientswithgravesdiseaseneedtobeeuthyroidpriortosurgery